The Loss of Muscle Tissue in Liver Transplant Patients

Overview

About this study

Diagnosing sarcopenia using modalities that can be used in routine clinical care is important. Our study will aim to assess the efficacy of the sarcopenia model. If results from this model are highly correlated to the gold standard, CT, then its use will allow for assessment of sarcopenia in routine clinical care.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

A multicentre study and will include all patients who have received a Liver Transplant at the Mayo Clinic in Rochester, Minnesota, and at the University of Alberta in Edmonton, Canada.

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Kymberly Watt, M.D.

Closed for enrollment

Contact information:

Kymberly Watt M.D.

127or7746247

Watt.Kymberly@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20307297

Mayo Clinic Footer